Trending...
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- RNHA FL Unveils Bold New Leadership Ahead of 2026 Elections
SAN DIEGO - Californer -- Mcl-1L Cytoplasmic Domain Human Recombinant
Mcl-1L Cytoplasmic Domain Human Recombinant is a high quality member of the Bcl-2 family of proteins, which play a key role in regulating apoptosis (programmed cell death) and cell survival. The cytoplasmic domain of Mcl-1L is a specific region of the protein that is involved in its cellular functions. This recombinant protein can be used in research to study the function and regulation of Mcl-1L, as well as its interactions with other proteins involved in cell survival and apoptosis. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Mcl-1L Cytoplasmic Domain Human Recombinant
Catalog number: B2016818
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg
More on The Californer
Molecular Weight or Concentration: 36 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Bcl-2-like Protein 3, EAT/Mcl-1, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1, Mcl-1 Long Isoform
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Kim JH, Bae J. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis PLoS One. 2013 Nov 18;8(11):e79626.
2: Fukumoto T, Iwasaki T, Okada T, Hashimoto T, Moon Y, Sakaguchi M, Fukami Y, Nishigori C, Oka M. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis Genes Cells. 2016 Feb;21(2):185-99.
https://moleculardepot.com/product/mcl-1l-cytoplasmic-domain-human-recombinant/
Mcl-1L Cytoplasmic Domain Human Recombinant is a high quality member of the Bcl-2 family of proteins, which play a key role in regulating apoptosis (programmed cell death) and cell survival. The cytoplasmic domain of Mcl-1L is a specific region of the protein that is involved in its cellular functions. This recombinant protein can be used in research to study the function and regulation of Mcl-1L, as well as its interactions with other proteins involved in cell survival and apoptosis. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Mcl-1L Cytoplasmic Domain Human Recombinant
Catalog number: B2016818
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg
More on The Californer
- Long Beach Recognizes National Childhood Lead Poisoning Prevention Week 2025
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- Federal reductions to critical services threaten public safety as flood season gets underway in California
- California steps up to help military, veteran families while the federal government is AWOL
Molecular Weight or Concentration: 36 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Bcl-2-like Protein 3, EAT/Mcl-1, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1, Mcl-1 Long Isoform
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Kim JH, Bae J. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis PLoS One. 2013 Nov 18;8(11):e79626.
2: Fukumoto T, Iwasaki T, Okada T, Hashimoto T, Moon Y, Sakaguchi M, Fukami Y, Nishigori C, Oka M. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis Genes Cells. 2016 Feb;21(2):185-99.
https://moleculardepot.com/product/mcl-1l-cytoplasmic-domain-human-recombinant/
Source: Molecular Depot
0 Comments
Latest on The Californer
- Premier Workspaces Elevates Its San Francisco Presence at One Sansome Street
- Coming Up this Weekend on CNBC Mike Milligan Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- City of Long Beach Launches Local Hiring Preferences
- The Mogharebi Group Facilitates $34.6 Million Sale of Willow Grove Apartments in Modesto, CA
- UK Website Launches "Toy Time Machine" — Find Your Childhood Christmas Toy in One Click
- Rachel Farris, CPA Named Among Forbes' Top CPAs in America
- California: Crime is down in San Francisco, key law enforcement partnerships yield successful results
- Scott St. Germain, U.S. Army Veteran and Vice President at Genentech, Joins Dream Foundation Board
- New West Symphony: E.T. The Extra-Terrestrial in Concert
- Vesper Public Relations is selected as an official supplier of the LASEC Business Connect Program
- California announces coalition of Governors forming new alliance to protect public health from political interference
- $73.6M Pipeline, $10M Crypto Play & Legal Firepower: Why Investors Are Watching Cycurion (N A S D A Q: CYCU) Like a Hawk
- Grammy award-winning Cuban-Canadian artist Alex Cuba releases his 11th studio album, "Indole"
- Thread Advisory Group Launches to Help Retailers Turn Strategy Into Lasting Results
- QView Medical and Eve Wellness Announce Partnership to Advance Direct-to-Consumer Breast Cancer Screening With FDA-Approved AI
- New Article Reveals Common Pricing Pitfalls in Flooring Projects — And How to Avoid Them
- Inside the Practice of a Caring Dentist Bringing Personalized Care to La Jolla
- Airbus Defence and Space and Omnitronics Sign MoU to Advance Interoperability in Critical Communications
- City of Long Beach Confirms First Case of Clade I Mpox
- DERMA-CODE™ Introduces the World's First Synergistic Skincare Combining NAD+, PDRN, and Peptides